Medicaroid has received CE-MDR approval for its Hinotori surgical robot system, enabling the company to expand its robotic-assisted surgery platform into the European market.
Hinotori is designed to support minimally invasive surgery with eight-axis robotic arms that replicate surgeons’ hand movements while reducing arm interference. The system also features a compact, docking-free design and a high-definition 3D imaging system to improve surgical precision and workflow.
Related: xDot Medical can begin FDA IDE study of vascular closure device
The CE mark builds on the system’s existing regulatory approval in Japan and represents a significant milestone in Medicaroid’s global commercialization strategy as it expands its healthcare robotics portfolio.
The company said:
“This marks an important milestone for Medicaroid and reflects the work of many dedicated teams who contributed their expertise and commitment along the way. Robotic-assisted surgery keeps moving forward, and we are proud to contribute to the advancement of minimally invasive surgery.”
The European approval positions Medicaroid to broaden the reach of its surgical robotics platform as demand for minimally invasive robotic procedures continues to grow.
